Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Progyny, Inc. before investing.

In this article, we go over a few key elements for understanding Progyny, Inc.’s stock price such as:

• Progyny, Inc.’s current stock price and volume
• Why Progyny, Inc.’s stock price changed recently
• Upgrades and downgrades for PGNY from analysts
• PGNY’s stock price momentum as measured by its relative strength

About Progyny, Inc. (PGNY)

Before we jump into Progyny, Inc.’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

Progyny, Inc., a benefits management company, provides fertility, family building, and women’s health benefits solutions in the United States. It offers fertility benefits solutions, such as differentiated benefits plan design that includes smart cycle treatment bundle; personalized concierge-style member support services; and a selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides access to the medications needed during their treatment and offers care management services, as well as pregnancy and postpartum, menopause and midlife, benefit and leave navigation, and parent and child wellbeing solutions. In addition, it provides assistance service program where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.

Want to learn more about Progyny, Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Progyny, Inc..

Progyny, Inc.’s Stock Price as of Market Close

As of August 21, 2026, 4:00 PM, CST, Progyny, Inc.’s stock price was $25.650.

Progyny, Inc. is down 1.19% from its previous closing price of $25.960.

During the last market session, Progyny, Inc.’s stock traded between $25.240 and $26.270. Currently, there are approximately 78.17 million shares outstanding for Progyny, Inc..

Progyny, Inc.’s price-earnings (P/E) ratio is currently at 28.6, which is high compared to the Health Care Providers & Services industry median of 25.8. The price-earnings ratio gauges market expectation of future performance by relating a stock’s current share price to its earnings per share.

Progyny, Inc. Stock Price History

Progyny, Inc.’s (PGNY) price is currently down 17.6% so far this month.

During the month of August, Progyny, Inc.’s stock price has reached a high of $31.820 and a low of $25.095.

Over the last year, Progyny, Inc. has hit prices as high as $33.065 and as low as $16.100. Year to date, Progyny, Inc.’s stock is down 0.12%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Progyny, Inc. Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of August 20, 2026, there was 1 analyst who downgraded Progyny, Inc.’s stock and 0 analysts who upgraded over the last month.

Additionally, you'll want to evaluate Progyny, Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Progyny, Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Progyny, Inc.’s current valuation based on AAII’s Value Grade is a C, which means it is considered to be Average.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Progyny, Inc. (PGNY) by visiting AAII Stock Evaluator.

Relative Price Strength of Progyny, Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of August 20, 2026, Progyny, Inc. has a weighted four-quarter relative price strength of 0.49%, which translates to a Momentum Score of 53 and is considered to be Average.

Want to learn more about how Progyny, Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Progyny, Inc. Stock Price: Bottom Line

As of August 21, 2026, Progyny, Inc.’s stock price is $25.650, which is down 1.19% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Progyny, Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.